A Phase Ⅲ Clinical Study of MIL62 in Primary Membranous Nephropathy
Clinical trial NCT05862233 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05862233
- Sponsor
- Beijing Mabworks Biotech Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-02
- Primary completion
- 2025-05-13
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.